Evidence map›Paper›PMID 41761059›Full record

ArticleBMC bioinformatics2026

A weight-sharing Bayesian neural network for consistent feature selection with applications in cancer gene expression data.

Akanksha Mishra, Wei Xia, Clint Pazhayidam George

Abstract read
In one paragraph

Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Akanksha MishraSchool of Mathematics and Computer Science, Indian Institute of Technology Goa, Ponda, Goa, 403401, India.
Wei XiaAmazon, Seattle, WA, USA.
Clint Pazhayidam GeorgeSchool of Mathematics and Computer Science, Indian Institute of Technology Goa, Ponda, Goa, 403401, India. clint@iitgoa.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdvances in sequencing technologies generate extensive genetic information. Datasets such as the Cancer Genome Atlas (TCGA) BRCA facilitate large-scale cancer gene expression analyses, providing insights into the molecular mechanisms driving tumor progression. Effective feature selection—identifying cancer or its subtype-related genes from expression profiles—is critical, as it enhances diagnostic accuracy and guides personalized therapies. However, feature selection is hindered by dimensionality, low sample sizes, and nonlinear interactions within the data, making traditional models, including LASSO and its Bayesian counterparts, inadequate for interpretable feature selection. We thus propose a novel weight-sharing Bayesian neural network (wsBNN) leveraging shared spike-and-slab priors within a neural network framework to enable adaptive weight shrinkage for efficient and interpretable feature selection.

resultsWe incorporate a scalable variational Bayes inference embedded in backpropagation while ensuring effective feature selection. Studying the theoretical properties of the variational posterior shows insights into the performance and theoretical guarantees of wsBNN. Both simulated and real-world dataset experiments show that wsBNN surpasses state-of-the-art nonlinear methods, including frequentist neural networks, in terms of predictive performance and consistency in feature selection. Furthermore, it competes well with classical methods such as Random Forests and Gradient Boosting. TCGA BRCA data study highlights wsBNN’s practical applicability in identifying key biomarkers, particularly in Breast Cancer analysis. The model effectively captured cancer-associated genes and pathways—particularly those related to ERBB2 and PI3K/AKT signaling, immune regulation, and cell cycle control—showing superior biological relevance and interpretability compared to baseline methods.

conclusionsOur findings—e.g., consistently identifying relevant biomarkers—position wsBNN as a promising approach for feature selection in high-dimensional genomic datasets and show its potential to advance precision medicine. By integrating weight-grouping with shared spike-and-slab priors within a Bayesian neural network, wsBNN effectively balances sparsity, interpretability, and scalability. wsBNN’s ability to recover biologically relevant genes and pathways highlights its importance for interpretable genomic analysis.

Indexed as

Computational BiologyGene Expression ProfilingNeoplasmsNeural Networks, ComputerBayes TheoremGene Expression Regulation, NeoplasticHumansBiomarker identificationCancer gene expressionHigh-dimensional dataPosterior consistencyPredictive modelingSpike-and-slab priorsVariational Bayes

Identifiers

PMID41761059
PMCPMC13041486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.